Jennifer Gjerde

1.2k total citations
29 papers, 938 citations indexed

About

Jennifer Gjerde is a scholar working on Genetics, Pharmacology and Pharmacology. According to data from OpenAlex, Jennifer Gjerde has authored 29 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 13 papers in Pharmacology and 10 papers in Pharmacology. Recurrent topics in Jennifer Gjerde's work include Estrogen and related hormone effects (20 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Inflammatory mediators and NSAID effects (10 papers). Jennifer Gjerde is often cited by papers focused on Estrogen and related hormone effects (20 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Inflammatory mediators and NSAID effects (10 papers). Jennifer Gjerde collaborates with scholars based in Norway, Italy and United States. Jennifer Gjerde's co-authors include Ernst A. Lien, Gunnar Mellgren, Elton R. Kisanga, Aliana Guerrieri‐Gonzaga, Andrea DeCensi, Vidar M. Steen, Steinar Lundgren, Davide Serrano, Jan Erik Varhaug and Giuseppe Pelosi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Jennifer Gjerde

28 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Gjerde Norway 18 483 295 293 230 157 29 938
Carrie A. Vyhlidal United States 21 279 0.6× 239 0.8× 221 0.8× 438 1.9× 106 0.7× 47 1.2k
Edgar S. Díaz‐Cruz United States 17 528 1.1× 69 0.2× 268 0.9× 356 1.5× 143 0.9× 30 1.1k
M. van Vliet Netherlands 15 159 0.3× 245 0.8× 204 0.7× 285 1.2× 93 0.6× 35 785
Carla J. Gallagher United States 18 197 0.4× 196 0.7× 130 0.4× 388 1.7× 77 0.5× 32 834
Cong Huai China 14 120 0.2× 242 0.8× 143 0.5× 493 2.1× 81 0.5× 30 1.0k
Gabriela Balogh United States 14 389 0.8× 62 0.2× 614 2.1× 529 2.3× 226 1.4× 35 1.3k
John P. Umland United States 14 123 0.3× 161 0.5× 312 1.1× 509 2.2× 95 0.6× 17 1.2k
Stephanie J. Webb United States 9 139 0.3× 130 0.4× 146 0.5× 533 2.3× 239 1.5× 9 980
Arun K. Agrawal United States 20 161 0.3× 393 1.3× 218 0.7× 314 1.4× 70 0.4× 37 1.4k
Sarah Chouinard Canada 11 157 0.3× 280 0.9× 136 0.5× 354 1.5× 82 0.5× 12 767

Countries citing papers authored by Jennifer Gjerde

Since Specialization
Citations

This map shows the geographic impact of Jennifer Gjerde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Gjerde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Gjerde more than expected).

Fields of papers citing papers by Jennifer Gjerde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Gjerde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Gjerde. The network helps show where Jennifer Gjerde may publish in the future.

Co-authorship network of co-authors of Jennifer Gjerde

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Gjerde. A scholar is included among the top collaborators of Jennifer Gjerde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Gjerde. Jennifer Gjerde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogdanović, Tanja, et al.. (2025). Microplastic Polymer Mass Fractions in Marine Bivalves: From Isolation to Hazard Risk. Journal of Xenobiotics. 15(6). 186–186.
2.
Bogdanović, Tanja, et al.. (2024). Bisfenoli - aditivi mikroplastike u morskim školjkašima. Veterinarska stanica. 56(1). 13–27. 1 indexed citations
3.
Johansson, Harriet, Valentina Aristarco, Sara Gandini, et al.. (2019). Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The Pharmacogenomics Journal. 20(1). 19–26. 9 indexed citations
4.
Kvaløy, Jan Terje, Kirsten Lode, Ragna Lind, et al.. (2019). Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. Breast Cancer Research and Treatment. 177(1). 185–195. 18 indexed citations
5.
Johansson, Harriet, Sara Gandini, Davide Serrano, et al.. (2016). A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen. Breast Cancer Research and Treatment. 159(1). 97–108. 11 indexed citations
6.
Gjerde, Jennifer, et al.. (2015). The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells. PLoS ONE. 10(4). e0122339–e0122339. 3 indexed citations
7.
Knappskog, Stian, et al.. (2015). Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer. PLoS ONE. 10(8). e0134351–e0134351. 8 indexed citations
8.
Bjørndal, Bodil, Elin Strand, Jennifer Gjerde, et al.. (2014). Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults. Lipids in Health and Disease. 13(1). 82–82. 24 indexed citations
9.
Aas, Turid, Kirsten Lode, Jennifer Gjerde, et al.. (2014). Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale. European Journal of Oncology Nursing. 19(2). 113–119. 48 indexed citations
10.
Lien, Ernst A., Håvard Søiland, Steinar Lundgren, et al.. (2013). Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment. Breast Cancer Research and Treatment. 141(2). 243–248. 46 indexed citations
11.
Serrano, Davide, Matteo Lazzeroni, Sara Gandini, et al.. (2013). A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Research. 15(3). R47–R47. 22 indexed citations
12.
Gjerde, Jennifer, André Madsen, Therese H. Røst, et al.. (2012). Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer. BMC Cancer. 12(1). 247–247. 11 indexed citations
13.
Gjerde, Jennifer, Sara Gandini, Aliana Guerrieri‐Gonzaga, et al.. (2012). Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide. Breast Cancer Research and Treatment. 134(2). 693–700. 30 indexed citations
14.
Dankel, Simon N., Jennifer Gjerde, Hans Jørgen Nielsen, et al.. (2011). The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. International Journal of Obesity. 36(9). 1195–1202. 54 indexed citations
15.
Serrano, Davide, Matteo Lazzeroni, Carlo‐Federico Zambon, et al.. (2010). Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial. The Pharmacogenomics Journal. 11(2). 100–107. 52 indexed citations
16.
Gjerde, Jennifer, Harald Breilid, Steinar Lundgren, et al.. (2007). Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. Annals of Oncology. 19(1). 56–61. 122 indexed citations
17.
Gjerde, Jennifer, et al.. (2005). Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1082(1). 6–14. 54 indexed citations
18.
Kisanga, Elton R., et al.. (2005). Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats. The Journal of Steroid Biochemistry and Molecular Biology. 94(5). 489–498. 8 indexed citations
19.
Kisanga, Elton R., Jennifer Gjerde, Aliana Guerrieri‐Gonzaga, et al.. (2004). Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial. Clinical Cancer Research. 10(7). 2336–2343. 163 indexed citations
20.
Kisanga, Elton R., Jennifer Gjerde, Jan Schjøtt, Gunnar Mellgren, & Ernst A. Lien. (2003). Tamoxifen administration and metabolism in nude mice and nude rats. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 361–367. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie A. Vyhlidal Breakdown of academic impact, for papers by Edgar S. Díaz‐Cruz Breakdown of academic impact, for papers by M. van Vliet Breakdown of academic impact, for papers by Carla J. Gallagher Breakdown of academic impact, for papers by Cong Huai Breakdown of academic impact, for papers by Gabriela Balogh Breakdown of academic impact, for papers by John P. Umland Breakdown of academic impact, for papers by Stephanie J. Webb Breakdown of academic impact, for papers by Arun K. Agrawal Breakdown of academic impact, for papers by Sarah Chouinard
Rankless by CCL
2026